Edwards Lifesciences Corp (NYSE: EW) is -4.98% lower on its value in year-to-date trading and has touched a low of $58.93 and a high of $96.12 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EW stock was last observed hovering at around $70.63 in the last trading session, with the day’s loss setting it -0.29%.
Currently trading at $70.34, the stock is -1.16% and -1.80% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.7 million and changing -0.41% at the moment leaves the stock -3.94% off its SMA200. EW registered -24.66% loss for a year compared to 6-month gain of 2.66%. The firm has a 50-day simple moving average (SMA 50) of $71.626 and a 200-day simple moving average (SMA200) of $73.22825.
The stock witnessed a -7.68% loss in the last 1 month and extending the period to 3 months gives it a -4.91%, and is 2.85% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.74% over the week and 2.43% over the month.
Edwards Lifesciences Corp (EW) has around 15800 employees, a market worth around $41.35B and $5.72B in sales. Current P/E ratio is 29.52 and Fwd P/E is 25.58. Profit margin for the company is 24.95%. Distance from 52-week low is 19.36% and -26.82% from its 52-week high. The company has generated returns on investments over the last 12 months (13.38%).
with sales reaching $1.4B over the same period.The EPS is expected to grow by 0.96% this year, but quarterly earnings will post 6.95% year-over-year. Quarterly sales are estimated to shrink -12.34% in year-over-year returns.
Edwards Lifesciences Corp (EW) Top Institutional Holders
1771.0 institutions hold shares in Edwards Lifesciences Corp (EW), with institutional investors hold 89.79% of the company’s shares. The shares outstanding are 588.60M, and float is at 576.41M with Short Float at 1.47%. Institutions hold 88.97% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 53.58 million shares valued at $4.95 billion. The investor’s holdings represent 8.9056% of the EW Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 50.98 million shares valued at $4.71 billion to account for 8.4733 of the shares outstanding. The other top investors are STATE STREET CORP which holds 26.01 million shares representing 4.3197% and valued at over $2.4 billion, while ALLIANCEBERNSTEIN L.P. holds 3.3812 of the shares totaling 20.34 million with a market value of $1.88 billion.
Edwards Lifesciences Corp (EW) Insider Activity
The most recent transaction is an insider sale by BOBO DONALD E JR, the company’s CVP,Strategy/Corp Development. SEC filings show that BOBO DONALD E JR sold 9,500 shares of the company’s common stock on Mar 13 ’25 at a price of $67.96 per share for a total of $0.65 million. Following the sale, the insider now owns 46936.0 shares.
Edwards Lifesciences Corp disclosed in a document filed with the SEC on Mar 10 ’25 that Zovighian Bernard J (CEO) sold a total of 6,164 shares of the company’s common stock. The trade occurred on Mar 10 ’25 and was made at $69.51 per share for $0.43 million. Following the transaction, the insider now directly holds 59083.0 shares of the EW stock.
Still, SEC filings show that on Mar 10 ’25, Lippis Daniel J. (CVP, JAPAC) disposed off 400 shares at an average price of $69.48 for $27792.0. The insider now directly holds 22,588 shares of Edwards Lifesciences Corp (EW).
